Bruker (BRKR) revenue

Revenue · fiscal 2025
$3.44B

Bruker (BRKR) reported revenue of $3.44B in fiscal 2025 (the year ended December 31, 2025). That is 2.1% higher than the $3.37B of fiscal 2024. Figures as of 18 Nov 2026, 12:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$3.44B
Change on fiscal 2024
+2.1%
Growth, 5 years
+11.6% a year
Growth, 10 years
+7.8% a year
Highest on record
$3.44Bfiscal 2025
Lowest on record
$1.11Bfiscal 2009
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bruker revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 11.6% a year; over ten years the rate was 7.8% a year. Across the 17 fiscal years on record (2009–2025), the highest was $3.44B in fiscal 2025 and the lowest $1.11B in fiscal 2009.

History · 17 fiscal years

Revenue by fiscal year

Bruker revenue, year by year

Bruker (BRKR) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$3.44B 2.1% up
2024$3.37B 13.6% up
2023$2.96B 17.1% up
2022$2.53B 4.7% up
2021$2.42B 21.7% up
2020$1.99B 4.1% down
2019$2.07B 9.3% up
2018$1.90B 7.3% up
2017$1.77B 9.6% up
2016$1.61B 0.8% down
2015$1.62B 10.2% down
2014$1.81B 1.7% down
2013$1.84B 2.7% up
2012$1.79B 8.5% up
2011$1.65B 26.6% up
2010$1.30B 17.1% up
2009$1.11B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Bruker and comparable companies
CompanyRevenueFiscal year
Spyre Therapeutics SYRE$886.00K2023
Qiagen QGEN$2.09B2025
Insulet PODD$2.71B2025
Bruker BRKR$3.44B2025
Globus Medical GMED$2.94B2025
Madrigal Pharmaceuticals MDGL$958.40M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BRKR

Bruker, figure by figure

Bruker (BRKR) overview: price, valuation and scorecardAll health care companies by market value

Bruker revenue: questions and answers

What is Bruker's revenue?

Bruker (BRKR) reported revenue of $3.44B in fiscal 2025 (the year ended December 31, 2025). That is 2.1% higher than the $3.37B of fiscal 2024.

What is the growth rate of Bruker's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 11.6% a year; over ten years the rate was 7.8% a year.

What are the highest and lowest revenue figures on record for Bruker?

Across the 17 fiscal years on record (2009–2025), the highest was $3.44B in fiscal 2025 and the lowest $1.11B in fiscal 2009.

How is Bruker's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Bruker it is on record here for 17 fiscal years, 2009 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bruker (BRKR) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/BRKR/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.